phone-icon(+035) 527-1710-70
email-icongoogle@gmail.com
map-iconChoose an address
Eastgate Biotech Eastgate Biotech
  • Home
  • About Us
    • Management
  • Technology
    • Research
    • Intraoral Insulin
  • Products
  • Investors
    • Press Releases
    • SEC Filings
  • Media
    • Dr. Luc Duchesne
    • Investor Intel
    • Investor Wired
    • StockHouse
    • TechSonian
    • PharmaLot
  • Contact Us
Menu
Eastgate Biotech Eastgate Biotech
  • NEWSLETTER
  • CONTACT US
  • FAQs
  • SPECIAL OFFER
  • PURCHASE THEME

Posts by admin

Home » Articles Posted by admin (Page 3)
09 Mar
Uncategorized

EastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr Lalit Upadhyay for Upcoming Initiatives

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
Key Opinion Leader spreading awareness of diabetes endorses the company’s liquid insulin mouth rinse solution for Type 2 diabetes and p...

Continue reading

09 Mar
Uncategorized

CORRECTED LINK: CEO Anna Gluskin’s interview with Uptick Newswire on 17 October 2018

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
https://upticknewswire.com/interview-ceo-anna-gluskin-of-eastgate-biotech-corp-otcpink-etbi/

Continue reading

09 Mar
Uncategorized

CEO Anna Gluskin, Interview with Uptick Network on October 17, 2018

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
https://upticknewswire.com/wp-content/uploads/2018/10/Uptick-Network-ETBI-Interview-10-17-18.mp3

Continue reading

09 Mar
Uncategorized

CEO Anna Gluskin’s interview-Uptick network 17Oct2018

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
https://upticknewswire.com/wp-content/uploads/2018/10/Uptick-Network-ETBI-Interview-10-17-18.mp3

Continue reading

09 Mar
Uncategorized

EastGate Biotech Signs Definitive Investment

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
Non-Dilutive Investment and Product License includes licensing fee and development costs WEST CALDWELL, N.J. and TORONTO, August 27, 2...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Provides Update on investment from Genluiching Mining Corporation

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EastGate Biotech Provides Update on investment from Genluiching Mining Corporation.   EastGate to receive the first non-dilut...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Expands Indications of Liquid Insulin Mouth Rinse Solution to Alzheimer’s Disease with Joint Venture Partner Genome Pharmaceuticals

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
Genome Pharma is the parent company of Netris/Origin BioPharmaceuticals the company’s Joint Venture Partner     WEST CALD...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Unveils Manufacturing Plans in an MOU with Mystic Pharmaceuticals Limited for its Liquid Insulin Mouth Rinse Solution

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
WEST CALDWELL, NJ and TORONTO, June 21, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company that...

Continue reading

09 Mar
Uncategorized

Morphs into Global Licensing Play with $36 Million in Milestone Payments

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EastGate is more than just a drug development company with an oral insulin formulation and an Aging Clinic Surgery Center in Canada. It...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Strikes Investment and Licensing Collaboration with Nico Innovapharma for Liquid Insulin Mouth Rinse Solution for the European Market

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
FOR IMMEDIATE RELEASE Investment and Product License includes licensing fee and development costs WEST CALDWELL, N.J. and TOR...

Continue reading

  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • ›
  • »

EastGate Biotech produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body.

2203-65 Harbour Square Toronto, Ontario M5J 2L4 Canada
Phone: +1 647 692 0652
WhatsApp: +1 647 692 0652
Our Office
  • New York
  • London SF
  • Cockfosters BP
  • Los Angeles
  • Chicago
  • Las Vegas
Innovative Alternatives to Conventional Pharmaceuticals.
  • Home
  • About Us
    • Management
  • Technology
    • Research
    • Intraoral Insulin
  • Products
  • Investors
    • Press Releases
    • SEC Filings
  • Media
    • Dr. Luc Duchesne
    • Investor Intel
    • Investor Wired
    • StockHouse
    • TechSonian
    • PharmaLot
  • Contact Us
  • Compare